Intra-Cellular Therapies (ITCI) Director Buys 50K Shares

September 14, 2020 5:10 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Intra-Cellular Therapies (NASDAQ: ITCI) Director, Christopher Alafi, bought 49,500 shares on 09/14 at $29.60.

Shares are held by Held by Alafi Capital Company,

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insider Trades

Related Entities

The Children's Investment Fund (TCI)